Rankings
▼
Calendar
CMPX FY 2023 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CMPX
Compass Therapeutics, Inc.
$781M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$50M
Net Income
-$42M
EPS (Diluted)
$-0.33
Cash Flow
Operating Cash Flow
-$41M
Free Cash Flow
-$41M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$157M
Total Liabilities
$8M
Stockholders' Equity
$149M
Cash & Equivalents
$24M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$50M
-$42M
-20.9%
Net Income
-$42M
-$39M
-8.3%
← Q4 2022
All Quarters
Q1 2023 →